Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px
Organisation › Details

Servier (Group)

Servier is an independent French research-based pharmaceutical company. Its development is driven by the pursuit of innovation in the therapeutic areas of cardiovascular, metabolic, central nervous system, psychiatric, rheumatologic diseases, as well as cancer. In 2014, the company recorded a turnover of 4 billion euros. 92% of Servier medicines are prescribed outside of France. 28% of turnover from Servier drugs was reinvested in Research and Development in 2014. With a strong international presence in 146 countries, Servier employs more than 21 400 people worldwide. *

 

Period Start 1954-01-01 established
Products Industry pharmaceutical
  Industry 2 cancer drug
Person Person Seta, Jean-Philippe (Servier 2003–201310 CEO joined Servier 1984 LEFT 201310)
     
Region Region Suresnes
  Country France
  Street 50 rue Carnot
  City 92284 Suresnes Cedex
  Tel +33-1-5572-6000
    Address record changed: 2014-11-26
     
Basic data Employees H: 10,001 to 50,00 (2015-07-08)
  Currency EUR
  Annual sales 4,000,000,000 (turnover (2014) 2014-12-31)
     
    * Document for �About Section�: Cellectis S.A.. (7/8/15). "Press Release: Cellectis Reaches Milestone in Servier Collaboration". New York, NY.
     
   
Record changed: 2018-11-28

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Servier (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px




» top